StonvexLoading…
StonvexStonvexStonvexCore line items from HZO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.31B | $2.43B | $2.39B | $2.31B |
Operating Income | $34.02M | $128.23M | $200.80M | $265.20M |
Net Income | $-31.63M | $38.07M | $109.28M | $197.99M |
EPS (Diluted) | $-1.43 | $1.65 | $4.87 | $8.84 |
Total Assets | $2.47B | $2.61B | $2.42B | $1.35B |
Total Liabilities | $1.52B | $1.62B | $1.50B | $570.11M |
Cash & Equivalents | $170.35M | $224.33M | $201.46M | $228.27M |
Free Cash Flow OCF − CapEx | $11.94M | $-86.08M | $-287.64M | $18.14M |
Shares Outstanding | 21.87M | 22.54M | 22.11M | 21.67M |